Th-17 regulatory cytokines IL-21, IL-23, and IL-6 enhance neutrophil production of IL-17 cytokines during asthma
- 2 March 2017
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Asthma
- Vol. 54 (9), 893-904
- https://doi.org/10.1080/02770903.2017.1283696
Abstract
Background: In a subset of severe asthma patients, chronic airway inflammation is associated with infiltration of neutrophils, Th-17 cells and elevated expression of Th-17-derived cytokines (e.g., interleukin [IL]-17, IL-21, IL-22). Peripheral neutrophils from allergic asthmatics are known to express higher IL-17 cytokine levels than those from healthy subjects, but the regulatory mechanisms involved are not well understood. We hypothesize that Th-17 regulatory cytokines could modulate IL-17 expression in neutrophils. Methods: Peripheral blood neutrophils isolated from asthmatics were stimulated with IL-21, IL-23, and IL-6 cytokines and their ability to produce IL-17A and IL-17F was determined relative to healthy controls. Signal transducer and activator of transcription 3 (STAT3) phosphorylation levels were measured in stimulated neutrophil using flow cytometry. The requirement for STAT3 phosphorylation was determined by blocking its activation using a specific chemical inhibitor. Results: Stimulating asthmatic neutrophils with IL-21, 23, and 6 enhanced the production of IL-17A and IL-17F at significantly higher levels comparatively to healthy controls. Stimulating neutrophils with IL-21, IL-23, and IL-6 cytokines enhanced STAT3 phosphorylation, in all cases. Interestingly, inhibiting STAT3 phosphorylation using a specific chemical inhibitor dramatically blocked the ability of neutrophils to produce IL-17, demonstrating that STAT3 activation is the major factor mediating IL-17 gene expression. Conclusions: These findings suggest that neutrophil infiltration in lungs of severe asthmatics may represent an important source of pro-inflammatory IL-17A and -F cytokines, a production enhanced by Th-17 regulatory cytokines, and thus providing a feedback mechanism that sustains inflammation. Our results suggest that STAT3 pathway could be a potential target for regulating neutrophilic inflammation during severe asthma.Keywords
This publication has 70 references indexed in Scilit:
- Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of ArthritisPLOS ONE, 2013
- Neutrophils cascading their way to inflammationTrends in Immunology, 2011
- Functional Specialization of Interleukin-17 Family MembersImmunity, 2011
- Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5Nature Immunology, 2011
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type IThe Journal of Experimental Medicine, 2010
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokinesThe Journal of Experimental Medicine, 2010
- Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 The Journal of Experimental Medicine, 2008
- Th17 cells: Effector T cells with inflammatory propertiesSeminars in Immunology, 2007
- Th17: the third member of the effector T cell trilogyCurrent Opinion in Immunology, 2007
- IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent MannerJournal of Biological Chemistry, 2007